Tag: 3-Health products | 2-Advisory

Uncategorized

Unauthorized products may pose serious health risks (October 21, 2020)

Posted on

Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. Thetable belowis updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid, or as “poppers,” and that are labelled to contain or have been tested and found to contain dangerous ingredients. Links to previous tables with affected products are also available below.

Uncategorized

Unauthorized products may pose serious health risks (October 21, 2020)

Posted on

Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. Thetable belowis updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid, or as “poppers,” and that are labelled to contain or have been tested and found to contain dangerous ingredients. Links to previous tables with affected products are also available below.

Uncategorized

Ultraviolet (UV) lights and wands falsely claiming to disinfect against COVID-19

Posted on

Health Canada is warning Canadians about the risks of using ultraviolet (UV) lights and wands that make unproven claims to disinfect against the COVID-19 virus. This includes ultraviolet C (UVC) products. UVC is an extremely dangerous form of UV radiation and, although it can destroy some germs on non-porous surfaces, if used on the skin, there is a risk that it can cause harm or injury. The World Health Organization (WHO) has warned against the use of UV light to disinfect hands or any other part of the body because of the risk of damage to the skin and eyes.

Uncategorized

Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) beyond 20 weeks of pregnancy and risk of kidney damage in unborn babies, leading to low amniotic fluid

Posted on

Health Canada is investigating the use of non-steroidal anti-inflammatory drugs (NSAIDs) at 20 weeks or later in pregnancy and the rare, but serious, risk of kidney problems in an unborn baby, in response to a Drug Safety Communication recently released by the U.S. Food and Drug Administration (FDA) on this issue.

Uncategorized

Updates to safety labelling for benzodiazepines and benzodiazepine-like drugs

Posted on

OTTAWA – Benzodiazepines and benzodiazepine-like prescription drugs (commonly referred to as “Z-drugs)—commonly used to treat sleep and anxiety disorders, certain seizure disorders, and to help relax muscles or relieve muscle pain—can lead to problematic use and substance use disorder. To help mitigate these risks, Health Canada is asking manufacturers to update their safety warnings to include more prominent and consistent messaging for patients and healthcare professionals.

Uncategorized

Laboratoire Atlas Inc. is recalling one lot of “ATLAS – Codeine phosphate syrup 5 mg/mL” because some bottles contain isopropyl rubbing alcohol

Posted on

Product: ATLAS – Codeine phosphate syrup 5 mg/mL (DIN 00050024) lot number 35MC, expiry date 2023-03, Laboratoire Atlas Inc. Issue: One lot of ATLAS – Codeine phosphate syrup 5 mg/mL is being recalled because some bottles contain isopropyl rubbing alcohol 70%. What to do: Stop taking product from the affected lot and obtain a replacement product from your pharmacist. Consult with your doctor or pharmacist if you have any questions or concerns.